Starting from a naphthol-based lead series with low oral bioavailability, we have identified potent TRPV1 antagonists with oral bioavailability in rats. These compounds emerged from SAR studies aimed at replacing the lead's phenol structure whilst maintaining potency. Compound rac-6a is an orally available TRPV1 antagonist with single-digit nanomolar activity. The enantiomers show a low eudismic ratio at the receptor level.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2012.03.108 | DOI Listing |
Publication Analysis
Top Keywords
orally trpv1
8
oral bioavailability
8
tetrahydro-naphthols orally
4
trpv1 inhibitors
4
inhibitors starting
4
starting naphthol-based
4
naphthol-based lead
4
lead series
4
series low
4
low oral
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!